These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9007205)

  • 1. Stavudine selectively induces apoptosis in HIV type 1-infected cells.
    Hashimoto KI; Tsunoda R; Okamoto M; Shigeta S; Baba M
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):193-9. PubMed ID: 9007205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
    Izopet J; Bicart-See A; Pasquier C; Sandres K; Bonnet E; Marchou B; Puel J; Massip P
    J Med Virol; 1999 Dec; 59(4):507-11. PubMed ID: 10534734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro.
    Merrill DP; Moonis M; Chou TC; Hirsch MS
    J Infect Dis; 1996 Feb; 173(2):355-64. PubMed ID: 8568296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the human immunodeficiency virus type 1 reverse transcriptase gene observed in stavudine and didanosine strains obtained by in vitro passages.
    Bossi P; Yvon A; Mouroux M; Huraux JM; Agut H; Calvez V
    Res Virol; 1998; 149(6):355-61. PubMed ID: 9923011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-retrovirals].
    Roca B; Simón E
    Med Clin (Barc); 1997 Jun; 109(2):62-7. PubMed ID: 9280805
    [No Abstract]   [Full Text] [Related]  

  • 6. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.
    Caron M; Auclair M; Lagathu C; Lombès A; Walker UA; Kornprobst M; Capeau J
    AIDS; 2004 Nov; 18(16):2127-36. PubMed ID: 15577645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudine.
    Turriziani O; Scagnolari C; Bambacioni F; Bellomi F; Focher F; Gentile M; Antonelli G
    Antivir Ther; 2002 Jun; 7(2):105-11. PubMed ID: 12212922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.
    Uckun FM; Pendergrass S; Venkatachalam TK; Qazi S; Richman D
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3613-6. PubMed ID: 12384373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.
    Paolucci S; Baldanti F; Campanini G; Cancio R; Belfiore A; Maga G; Gerna G
    Antiviral Res; 2007 Nov; 76(2):99-103. PubMed ID: 17640745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decrease of HIV-1 replicative capacity after serial passage in MT-4 cells under conditions of the combined antiretroviral therapy].
    Selimova LM; Khanina TA; Galegov GA
    Antibiot Khimioter; 2003; 48(6):7-10. PubMed ID: 14558412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens.
    Ross L; Henry K; Paar D; Salvato P; Shaefer M; Fisher R; Liao Q; St Clair M
    J Hum Virol; 2001; 4(4):217-22. PubMed ID: 11694850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
    Uckun FM; Qazi S; Venkatachalam TK
    Arzneimittelforschung; 2005; 55(4):223-31. PubMed ID: 15901046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase.
    Gavriliu D; Fossey C; Ciurea A; Delbederi Z; Sugeac E; Ladurée D; Schmidt S; Laumond G; Aubertin AM
    Nucleosides Nucleotides Nucleic Acids; 2002; 21(8-9):505-33. PubMed ID: 12484448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished HIV-1 sensitivity to stavudine in patients on prolonged therapy occurs only at low levels and cannot be attributed to any single amino acid substitution in reverse transcriptase.
    Salomon H; Montaner JS; Belmonte A; Wainberg MA
    Antivir Ther; 1998; 3(3):177-82. PubMed ID: 10682135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains.
    Zhu QY; Scarborough A; Polsky B; Chou TC
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):507-17. PubMed ID: 8679306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
    Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
    Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity.
    Witvrouw M; Arranz ME; Pannecouque C; Declercq R; Jonckheere H; Schmit JC; Vandamme AM; Diaz JA; Ingate ST; Desmyter J; Esnouf R; Van Meervelt L; Vega S; Balzarini J; De Clercq E
    Antimicrob Agents Chemother; 1998 Mar; 42(3):618-23. PubMed ID: 9517942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase.
    Bradshaw D; Malik S; Booth C; Van Houtte M; Pattery T; Waters A; Ainsworth J; Geretti AM
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4489-91. PubMed ID: 17876005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.
    Ross L; Scarsella A; Raffanti S; Henry K; Becker S; Fisher R; Liao Q; Hirani A; Graham N; St Clair M; Hernandez J;
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1107-15. PubMed ID: 11522180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.
    Crespan E; Locatelli GA; Cancio R; Hübscher U; Spadari S; Maga G
    Antimicrob Agents Chemother; 2005 Jan; 49(1):342-9. PubMed ID: 15616314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.